Risk-Adapted Treatment Strategy for COVID-19 Patients

International Journal of Infectious Diseases - Netherlands
doi 10.1016/j.ijid.2020.03.047
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Treatment With Convalescent Plasma for COVID-19 Patients in Wuhan, China

Journal of Medical Virology
VirologyInfectious Diseases
2020English

Can China's COVID-19 Strategy Work Elsewhere?

Science
MultidisciplinaryPhilosophy of ScienceHistory
2020English

Corticosteroid Treatment of Patients With Coronavirus Disease 2019 (COVID-19)

Medical Journal of Australia
Medicine
2020English

Biological Treatment During COVID-19 Outbreak

Journal of Dermatological Treatment
Dermatology
2020English

Care for Critically Ill Patients With COVID-19

JAMA - Journal of the American Medical Association
Medicine
2020English

Should Patients Stop Their Biologic Treatment During the COVID-19 Pandemic

Journal of Dermatological Treatment
Dermatology
2020English

Treatment of COVID-19: Old Tricks for New Challenges

Critical Care
Critical CareIntensive Care Medicine
2020English

Venous Thromboembolism in COVID-19 Patients

Journal of Thrombosis and Haemostasis
MedicineHematology
2020English

Waiting for COVID-19

Journal of Paediatrics and Child Health
Child HealthPediatricsPerinatology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy